Blue Fin Group is a management consulting firm whose mission is to collaborate with healthcare companies of all sizes and stages, enabling them to achieve their strategic, operational, and financial potential. Our passion is connecting patients to products with a keen focus on the patient journey.
Why Choose Blue Fin Group?
Blue Fin Group focuses on long-range strategy, delivering a 5-year, multigenerational plan at the conclusion of each engagement. We guide you through a measured, defined process that organically adds value in a sustainable way. At the end of the five years is when we ask to be judged on the success of our advice. We are confident you will be pleased with the results.
We support your science, helping you build a commercial strategy that ensures affordable access to your product or service. You will receive a tailored business plan and related output structured for your unique situation. We carefully learn your organization’s particular needs, adjusting our methodology to best help you accomplish your business goals.
At Blue Fin Group, there are no sales people. The person who presents your business opportunity does the work to deliver it. Every team is staffed by 25, 15 and 5-years of experienced industry and consultant associates. This ensures the best mix of perspectives and knowledge while we design and optimize strategies to assist clients.
At the core of who we are is our individual authenticity, our skill in commercializing pharmaceuticals, our entrepreneurial work ethic and our ability to relate to other humans. We like to think of all the relationships across the company as a 1+1=3 combination. We are all good on our own, but we’re better together. We have each others interest in mind and we strive to continually better. At our weekly team meetings we recognize people for their support of our values, their ideas, and contributions. We are a “flat organization” meaning we don’t have hierarchy. Everyone is encouraged to connect with everyone else – regardless of level or tenure.
Meet the Team
Our company is governed by a dynamic team of industry thought leaders and market visionaries who are committed to helping our clients and our associates reach their peak potential. Our people are well-known in the industry for their deep cross-functional knowledge of commercialization and their unique forward-looking views on industry. Blue Fin Group has no practice areas; all of our consultants are skilled within and across all areas.
Bill is a recognized expert on business model development in healthcare. For over 25 years, he has helped both start-ups and industry leaders improve patient care, financial health and the strategic direction of their organizations.
Bill’s unique experience, skillset and knowledge has been built by working directly with almost every type of business model across the pharmaceutical industry.
As a highly sought-after thought leader, Bill is often cited by market researchers and analysts for his accurate predictions of future trends. He speaks frequently at industry conferences and was featured on the cover of Pharmaceutical Commerce in January 2016 as a leader in the sector.
John serves the pharmaceutical, pharmacy benefit management and health information management industries. He has produced award-winning results for Fortune 500 and entrepreneurial healthcare companies alike.
John excels at transforming strategy into operational success. He helps industry leaders to rationalize their products, portfolios, sales targets and approaches to the marketplace. John’s background spans commercial operations including sales, sales management, sales training, sales operations, managed markets (reimbursement, program/contract creation and negotiation, formulary access and management), customer service and support, product distribution (order-to-cash, product security), forecasting and financial management, and legal compliance. John has taken clients through projects that span the product lifecycle from FDA submissions through new product launches and extension strategies.
John has a Bachelors Degree in Finance from Providence College, where he is also an adjunct professor, and an MBA from NYU Stern School of Business.
Jennifer is a bio/pharmaceutical industry leader and financial professional with the ability to identify opportunities and challenges, developing ideal solutions with a practiced, pragmatic approach. She has extensive expertise across pharmaceutical commercial operations, which allows her to guide clients to successful commercialization strategies, creating optimal patient and provider experiences.
To ensure clients stay ahead of the curve in a rapidly changing environment, Jennifer delivers deep understanding of new legislation, regulations, and healthcare trends.
She is sought after by industry leaders as a sounding board and is considered a trusted advisor. Jennifer’s long experience in healthcare allows her to contextualize the unique aspects of each client’s situation and provide a tailored approach that is best-in-class, staying focused on prioritized objectives and flawless execution of the plan, preventing over-investing.
Jennifer holds a Bachelor of Science in Business and Economics, Accounting from Lehigh University.
Phyllis is an experienced bio pharmaceutical, healthcare and managed care leader with more than 30 years of experience in the industry. Her deep commercial and clinical experience provides unique insight, leading to effective, tailored solutions across many aspects of commercialization, helping clients successfully address their business challenges.
In addition to her experience as a consultant, Phyllis has a deep background in the pharmaceutical industry, both in market access and payer account management, as well as leading trade and channel teams. She has launched both traditional brands and specialty and orphan drugs, and designed payer and channel strategies for those products.
As a PharmD, Phyllis’s unique combination of clinical and business perspectives allows her to create practical solutions for complex problems. Her areas of expertise include market access, payer strategy and positioning, channel strategy, contracting strategy and development, as well as the management of orphan drugs.
Phyllis earned her PharmD at the University of Southern California and completed a post-PharmD residency at LAC-USC Medical Center.
Bruce is a recognized industry expert with significant expertise in delivering consulting services and subject matter expertise to clients in the life sciences sector, including distribution and dispensing channel management, product launch, patient service, payer access designs, in the orphan/rare and complex specialty product segments enabling products and clients to grow to their maximum capability.
He has a rich background in biotechnology, immunology, cell and gene therapy and complex pharmaceuticals, and specialty pharmacy as well as healthcare leadership, marketing, strategic planning, sales, sales management, sales training, and business development in the hospital, home health and community sites of care environments.
Bruce has extensive experience in the specialty product, cell and gene, protein, monoclonal and blood-product markets, with a focus on commercialization strategy, product portfolio management, site of care delivery logistics, and patient support services for complex therapies. He applies his analytic and strategic approach to market and delivery challenges when launching, optimizing, and maintaining conventional and specialty product therapies in a variety of healthcare settings.
Reena supports pharmaceutical manufacturers across the entire commercialization spectrum, primarily focusing on product commercialization launches, specifically strategy development and implementation around supply chain, channel and patient services, contracting, government pricing, gross to net and reimbursement/pricing. Her experience allows her to collaborate effectively with stakeholders across functional areas, delivering pragmatic, implementable full commercialization solutions across various product archetypes such as tweener, specialty and orphan/rare products.
Reena is also an expert in government pricing, contracting, compliance and an array of reimbursement topics, including helping to interpret and analyze the impact of healthcare policy areas. She also translates internal impacts to commercial customers, helping manufacturer clients interpret how their strategies will affect downstream and upstream stakeholders, building detailed gross to net (GTN) and revenue impact models.
Reena possesses the specialized professional knowledge to effectively advise clients on the complex healthcare ecosystem. Reena’s expertise is shown by her long-term relationships with clients, their in-house counsel, outside law firms, and other industry sources. She is focused on building strong, enduring relationships with her clients, and has gained their trust and confidence.
Reena holds a BS in Pharmaceutical and Healthcare Business from the Mayes College of Healthcare Business and Policy, University of Sciences in Philadelphia.